IPO this summer was good thing for nanotechnology, both short and long term. We should all be pleased with the state of nanotech in the fall of and the speed with which developments and commercial applications are occurring. Nanodots quantum dots are being manufactured in multiple locations and applied to identification and tracking uses that will shortly come to market, especially in the medical and pharmaceutical industries. The timetable for nanotechnology implementation, except possibly for those instances that include FDAapproval requirements, is excessively long. These are wonderfully positive assets.
We should be even more pleased with the state of nanotech in the fall of lets stop for moment to assess the health and momentum of the nanotech industry and its state of maturity. Every day, new application possibilities surface, more people enter nanotechnology as profession and discoveries are built on previously unique work. rudimentary nanobot movement has been performed using DNA segments and complements.
These are good lessons to learn.
word of caution Not all is rosy. Nanodots quantum dots are being manufactured in multiple locations and applied to identification and tracking uses that will shortly come to market, especially in the medical and pharmaceutical industries. We are still in the early development phase of the industry. Progress is tangible and specific. There are no clear winners in any economic segment of nanotechnology If this year is any model, next year should be amazingly productive and exciting.
There are no clear winners in any economic segment of nanotechnology there is proven methodology with more methods coming. Stake out your positions next year be too late. All momentum is positive and commercialization has accelerated. My sense is that reality will dominate in nanotechnology assessment, at least in the short term. Parallel efforts exist all over the world. One year nanobot movement was only modeled. We have yet to touch the toxicological, ethical and moral questions inherent in the application of nanotech in the world we live.
Many of these are beginning to show many tangible results. All the commercial opportunities are still available. Investors need to add more funding until these ventures develop real value, or modicum of maturity and presence in their markets, to justify those higher public multiples. there is proven methodology with more methods coming. We are only in the enabler and integrator segments of market growth. Because of the massive amount of funding and worldwide competition, nanotechnologys applications will occur far more rapidly and more broadly than predicted. year liquid could not be moved across nanoarray.
